FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Quallent)

View source ↗

Summary

FDA approved a supplemental application for Pravastatin Sodium submitted by Quallent, indicating an approved change to the product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)